4Levy DE. STAT stroke treatment with Ancrod Trial. Presented at the 21st International Joint Conference on Stroke and Cerebral Circulation. January 25, 1996, San Antonio. TX.
2Xu W, Chung DW, Davie EW. The assembly of human fibrinogen. The role of the amino-terminal and coiled-coil regions of the three chains in the formation of the alphagamma and betagamma heterodimers and alphabetagamma half-molecules. J Biol Chem, 1996, 271(
3Okumura N, Terasawa F, Tanaka H, et al. Analysis of fibrinogen gamma-chain truncations shows the C-terminus,particularly gammaIle387,is essential for assembly and secretion of this multichain protein. Blood, 2002, 99(10): 3654-3660.
4van′-t-Hooft FM, von-Bahr SJ, Silveira A, et al. Two common,functional polymorphisms in the promoter region of the beta-fibrinogen gene contribute to regulation of plasma fibrinogen concentration. Arterioscler Thromb Vasc Biol, 1999, 19(12): 3063-3070.
5Brown ET, Fuller GM. Detection of a complex that associates with the Bbeta fibrinogen G-455-A polymorphism. Blood, 1998, 92(9): 3286-3293.
6Iacoviello L, Vischetti M, Zito F, et al. Genes encoding fibrinogen and cardiovascular risk. Hypertension, 2001, 38(5): 1199-1203.
7Vu D, Bolton-Maggs PH, Parr JR, et al. Congenital afibrinogenemia: identification and expression of a missense mutation in FGB impairing fibrinogen secretion. Blood, 2003, 102(13): 4413-4415.
8Duga S, Asselta R, Santagostino E, et al. Missense mutations in the human beta fibrinogen gene cause congenital afibrinogenemia by impairing fibrinogen secretion. Blood, 2000, 95(4): 1336-13341.
9Brummel KE, Butenas S, Mann KG. An integrated study of fibrinogen during blood coagulation. J Biol Chem, 1999, 274(32): 22862-22870.
10Brummel KE, Butenas S, Mann KG. An integrated study of fibrinogen during blood coagulation.J Biol Chem,1999,274(32): 22862-22870.
